title: Radioprotective thiolamines WR-1065 and WR-33278 selectively denature nonhistone nuclear proteins.
abstract: Differential scanning calorimetry was used to study the interactions of nuclei isolated from Chinese hamster V79 cells with the radioprotector WR-1065, other thiol compounds, and polyamines. Differential scanning calorimetry monitors denaturation of macromolecules and resolves the major nuclear components (e.g. constrained and relaxed DNA, nucleosome core, and nuclear matrix) of intact nuclei on the basis of thermal stability. WR-1065 treatment (0.5-10 mM) of isolated nuclei led to the irreversible denaturation of nuclear proteins, a fraction of which are nuclear matrix proteins. Denaturation of 50% of the total nonhistone nuclear protein content of isolated nuclei occurred after exposure to 4.7 mM WR-1065 for 20 min at 23 degrees C. In addition, a 22% increase in the insoluble protein content of nuclei isolated from V79 cells that had been treated with 4 mM WR-1065 for 30 min at 37 degrees C was observed, indicating that WR-1065-induced protein denaturation occurs not only in isolated nuclei but also in the nuclei of intact cells. From the extent of the increase in insoluble protein in the nucleus, protein denaturation by WR-1065 is expected to contribute to drug toxicity at concentrations greater than approximately 4 mM. WR-33278, the disulfide form of WR-1065, was approximately twice as effective as the free thiol at denaturing nuclear proteins. The proposed mechanism for nucleoprotein denaturation is through direct interactions with protein cysteine groups with the formation of destabilizing protein-WR-1065 disulfides. In comparison to its effect on nuclear proteins in isolated nuclei, WR-1065 had only a very small effect on non-nuclear proteins of whole cells, isolated nuclear matrix, or the thiol-rich Ca(2+)ATPase of sarcoplasmic reticulum, indicating that WR-1065 can effectively denature protein only inside an intact nucleus, probably due to the increased concentration of the positively charged drug in the vicinity of DNA.
authors.affiliation: Guelph-Waterloo Program for Graduate Studies in Physics, University of Waterloo, Waterloo, Ontario N2L 3G1, Canada.
authors.forename: V K
authors.initials: VK
authors.lastname: Booth
authors.forename: J C
authors.initials: JC
authors.lastname: Roberts
authors.forename: R L
authors.initials: RL
authors.lastname: Warters
authors.forename: B H
authors.initials: BH
authors.lastname: Wilmore
authors.forename: J R
authors.initials: JR
authors.lastname: Lepock
mesh_terms: D000818:Animals; D002152:Calorimetry, Differential Scanning; D002460:Cell Line; D002467:Cell Nucleus / Q000187:drug effects / Q000378:metabolism; D002868:Chromosomal Proteins, Non-Histone / Q000737:chemistry*; D006224:Cricetinae; D003412:Cricetulus; D008624:Mercaptoethylamines / Q000494:pharmacology*; D011073:Polyamines / Q000494:pharmacology; D011489:Protein Denaturation; D011837:Radiation-Protective Agents / Q000494:pharmacology*
chemical_list: D002868:Chromosomal Proteins, Non-Histone; D008624:Mercaptoethylamines; D011073:Polyamines; D011837:Radiation-Protective Agents; C020174:N-(2-mercaptoethyl)-1,3-diaminopropane; C045611:WR 33278